向FOXM1重塑抗瘤免疫力,减弱小细胞肺癌的进展
Md Arafat Khan1, Parvez Khan1, Mahek Fatima1
1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE-68198, USA.
Cancer letters
|November 23, 2025
概括
向FOXM1显示出治疗小细胞肺癌 (SCLC) 的前景. 抑制FOXM1可以克服化学抵抗,并在SCLC模型中增强抗瘤免疫力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有攻击性的癌症,其特点是转移和化学抵抗.
- 有限的向疗法强调了在SCLC中需要新的治疗策略.
- FOXM1已成为SCLC的潜在治疗点.
研究的目的:
- 研究FOXM1在SCLC进展和化学抵抗中的作用.
- 评估在SCLC中FOXM1抑制的治疗潜力.
主要方法:
- 对单细胞和大批转录组数据集的分析.
- 使用SCLC细胞系和小鼠模型进行体外和体外研究.
- 用RNA测序来阐明分子机制.
- 对免疫细胞反应和瘤微环境的评估.
主要成果:
- 在人类和小鼠SCLC中,FOXM1的表达升高,特别是在耐化学性细胞中.
- 与化疗相结合的FOXM1抑制显示出协同作用的抗癌效应.
- 抑制FOXM1调节了光激酶B (AURKB) 途径.
- 抑制FOXM1增强了T细胞的激活,分化和瘤细胞的杀死.
- 抑制FOXM1促进了CD8+T细胞和巨细胞在瘤微环境中的透.
结论:
- 福克斯M1是SCLC进展和化学抵抗的关键驱动因素.
- 用小分子抑制剂 (FOXM1i) 向FOXM1代表了SCLC的潜在治疗策略.
- 抑制FOXM1可以克服化学抵抗并重塑SCLC中的抗瘤免疫反应.
更多相关视频
07:36Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
7.4K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.6K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
